NEW YORK, Oct 23 – Agilent Technologies said Monday it would supply custom microarray technology to genomics biomarker company DiaDexus.

DiaDexus will use the arrays for research into the molecular basis for cancer and other diseases. Financial details of the agreement were not disclosed, but the cost of Agilent’s arrays range from less than $500 to $1,000 per array.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.